Because APP overexpression lowers cellular copper [38], [39] and decreased copper levels exacerbates amyloid pathology [40], [41], we investigated whether the synergistic interplay between sod2 ablation and Alzheimer pathology in Tg2576 transgenics is reflected by lowered brain metal levels. The gene discussed is APP; the disease is amyloidosis.